Medtronic's Hugo™ robotic surgery system for robot-assisted radical prostatectomy: a systematic review of current worldwide experiences
- PMID: 39340731
- PMCID: PMC11438614
- DOI: 10.1007/s11701-024-02113-3
Medtronic's Hugo™ robotic surgery system for robot-assisted radical prostatectomy: a systematic review of current worldwide experiences
Abstract
Urology's pioneering role in surgical innovations, from cystoscopy to laparoscopic surgery, culminated in the twenty-first-century advent of robotic surgery. The dominant da Vinci® system faced new competition following its 2019 patent expiration. Medtronic's Hugo™ system emerged. Its growing global adoption, especially in robot-assisted radical prostatectomy (RARP), necessitates a systematic review, evaluating safety, feasibility, and comparison with established systems. A comprehensive search identified eligible studies of the Hugo™ robotic platform for RARP, presenting their current experiences. Following systematic screening, quality of eligible studies was assessed using ROBINS-I. Results then underwent a narrative synthesis. This systematic review analysed 19 eligible studies, consisting of 9 comparative and 10 single arm studies. Due to the non-randomised nature of the studies, a moderate risk of bias was concluded in most. On account of the high heterogeneity between studies, a narrative synthesis of data was enacted; categorised into themes relating to operative timings, transfer of skills, patient demographics, plus safety and feasibility. Eligible studies demonstrated the promise of the Hugo™ platform within these themes, in comparison to currently available platforms. Despite a paucity of high-quality randomised controlled trials, available evidence indicates Hugo™ as a promising, safe alternative for RARP. Positive experiences across diverse centres and surgeons revealed minimal differences in surgical outcomes compared to the established da Vinci® system, fostering global Hugo™ adoption. Despite evidence demonstrating Hugo™ safety and comparability, the review underscores the scarcity of high-quality evidence, attributing it to early stage implementation challenges.
Keywords: Da Vinci; Hugo; RARP; RAS; Robotic-assisted radical prostatectomy.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Ramai D et al (2018) Philipp Bozzini (1773–1809): the earliest description of endoscopy. J Med Biogr 26(2):137–141 - PubMed
-
- Soputro NA et al (2022) A historical perspective of the evolution of laparoscopic surgeries in urology. J Endourol 36(10):1277–1284 - PubMed
-
- Atife M et al (2024) Intuitive’s da Vinci vs Medtronic’s Hugo: real life observations from a robot naïve perspective. J Robot Surg 18(1):4 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
